Intestinal Neuroendocrine Neoplasm — Trials

Intestinal Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00569127	Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	active not recruiting	Phase 3	427	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials
NCT07759960	Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors	recruiting	N/A	174	Nanfang Hospital, Southern Medical UniversityOTHER	1	Aug 12, 2026	clinicaltrials
NCT02595424	Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas	active not recruiting	Phase 2	67	ECOG-ACRIN Cancer Research GroupNETWORK	1	Jul 27, 2026	clinicaltrials

Data updated 23 days agoSource updated Aug 28, 2026source: clinicaltrials